| Title : Soluble Epoxide Hydrolase Inhibition Prevents Experimental Type 4 Cardiorenal Syndrome - Hamzaoui_2020_Front.Mol.Biosci_7_604042 |
| Author(s) : Hamzaoui M , Roche C , Coquerel D , Duflot T , Brunel V , Mulder P , Richard V , Bellien J , Guerrot D |
| Ref : Front Mol Biosci , 7 :604042 , 2020 |
| Abstract : Hamzaoui_2020_Front.Mol.Biosci_7_604042 |
| ESTHER : Hamzaoui_2020_Front.Mol.Biosci_7_604042 |
| PubMedSearch : Hamzaoui_2020_Front.Mol.Biosci_7_604042 |
| PubMedID: 33777999 |
| Title : Altered bioavailability of epoxyeicosatrienoic acids is associated with conduit artery endothelial dysfunction in type 2 diabetic patients - Duflot_2019_Cardiovasc.Diabetol_18_35 |
| Author(s) : Duflot T , Moreau-Grange L , Roche C , Iacob M , Wils J , Remy-Jouet I , Cailleux AF , Leuillier M , Renet S , Li D , Morisseau C , Lamoureux F , Richard V , Prevost G , Joannides R , Bellien J |
| Ref : Cardiovasc Diabetol , 18 :35 , 2019 |
| Abstract : Duflot_2019_Cardiovasc.Diabetol_18_35 |
| ESTHER : Duflot_2019_Cardiovasc.Diabetol_18_35 |
| PubMedSearch : Duflot_2019_Cardiovasc.Diabetol_18_35 |
| PubMedID: 30885203 |
| Title : Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice - Roche_2015_Am.J.Physiol.Heart.Circ.Physiol_308_H1020 |
| Author(s) : Roche C , Besnier M , Cassel R , Harouki N , Coquerel D , Guerrot D , Nicol L , Loizon E , Remy-Jouet I , Morisseau C , Mulder P , Ouvrard-Pascaud A , Madec AM , Richard V , Bellien J |
| Ref : American Journal of Physiology Heart Circ Physiol , 308 :H1020 , 2015 |
| Abstract : Roche_2015_Am.J.Physiol.Heart.Circ.Physiol_308_H1020 |
| ESTHER : Roche_2015_Am.J.Physiol.Heart.Circ.Physiol_308_H1020 |
| PubMedSearch : Roche_2015_Am.J.Physiol.Heart.Circ.Physiol_308_H1020 |
| PubMedID: 25724490 |
| Title : Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice - Roche_2015_Prostaglandins.Other.Lipid.Mediat_120_148 |
| Author(s) : Roche C , Guerrot D , Harouki N , Duflot T , Besnier M , Remy-Jouet I , Renet S , Dumesnil A , Lejeune A , Morisseau C , Richard V , Bellien J |
| Ref : Prostaglandins Other Lipid Mediat , 120 :148 , 2015 |
| Abstract : Roche_2015_Prostaglandins.Other.Lipid.Mediat_120_148 |
| ESTHER : Roche_2015_Prostaglandins.Other.Lipid.Mediat_120_148 |
| PubMedSearch : Roche_2015_Prostaglandins.Other.Lipid.Mediat_120_148 |
| PubMedID: 26022136 |
| Title : Design and discovery of soluble epoxide hydrolase inhibitors for the treatment of cardiovascular diseases - Duflot_2014_Expert.Opin.Drug.Discov_9_229 |
| Author(s) : Duflot T , Roche C , Lamoureux F , Guerrot D , Bellien J |
| Ref : Expert Opin Drug Discov , 9 :229 , 2014 |
| Abstract : Duflot_2014_Expert.Opin.Drug.Discov_9_229 |
| ESTHER : Duflot_2014_Expert.Opin.Drug.Discov_9_229 |
| PubMedSearch : Duflot_2014_Expert.Opin.Drug.Discov_9_229 |
| PubMedID: 24490654 |